» Articles » PMID: 19223076

MRI of the Spinal Cord in Neuromyelitis Optica and Recurrent Longitudinal Extensive Myelitis

Overview
Journal J Neuroradiol
Specialties Neurology
Radiology
Date 2009 Feb 19
PMID 19223076
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Neuromyelitis optica (NMO) is a severe inflammatory and necrotizing disease that clinically affects the optic nerves and spinal cord in a relapsing course. We assessed the baseline and follow-up MRI characteristics of cord attacks in NMO and recurrent longitudinal extensive myelitis (RLEM).

Methods: We retrospectively reviewed MRI data of 20 Afro-Caribbean patients diagnosed with either NMO or RLEM. MRI data from 51 cord or mixed attacks were evaluated, and 65 follow-up MRI studies were available for 30 baseline acute examinations.

Results: The cervical cord was involved in 63% of cases. Four attacks were limited to the brainstem. MRI of the spinal cord revealed longitudinal extensive signal abnormalities extending over three vertebral segments, associated with cord swelling in 67% of the 51 relapses. Gadolinium enhancement was observed, preferentially surrounding edema, in 69% of attacks. In the axial plane, signal abnormalities typically involved central areas of the cord. Cavitation was observed in 16% of attacks. Cord attacks recurred in the same or contiguous areas in 67% of cases. Follow-up MRI revealed a gradual decrease in cord swelling and T2 signal hyperintensity, with fragmentation of signal abnormalities in some cases. Cord atrophy was evident in 57% of the follow-up MRI.

Conclusion: Given the poor prognosis of NMO and RLEM, radiologists need to be aware of the MRI pattern to prevent further attacks with the use of aggressive treatment.

Citing Articles

Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ.

Nakajima A, Yanagimura F, Saji E, Shimizu H, Toyoshima Y, Yanagawa K Acta Neuropathol. 2024; 147(1):76.

PMID: 38658413 DOI: 10.1007/s00401-024-02725-x.


T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study.

Hashemi M, Talebi V, Kasbi N, Abbasi M, Asgari N, Sahraian M BMC Neurol. 2024; 24(1):62.

PMID: 38347476 PMC: 10860265. DOI: 10.1186/s12883-024-03550-1.


Patterns of Adult Neuromyelitis Optica Spectrum Disorder Patients Compared to Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Alqwaifly M, Althobaiti A, AlAibani N, Banjar R, Alayed R, Alsubaie S Cureus. 2023; 15(10):e47565.

PMID: 38021935 PMC: 10666196. DOI: 10.7759/cureus.47565.


Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean.

Chaumont H, Berard N, Karam J, Lobjois Q, Tressieres B, Signate A Neurol Neuroimmunol Neuroinflamm. 2023; 11(1).

PMID: 37949668 PMC: 10691227. DOI: 10.1212/NXI.0000000000200175.


Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.

Prasad C, Kopp C, Naidu G, Sharma V, Misra D, Agarwal V Rheumatol Int. 2023; 44(12):2807-2815.

PMID: 37500817 DOI: 10.1007/s00296-023-05397-0.